Clinical Trials Directory

Trials / Completed

CompletedNCT04379193

Physical Therapy and Neuroactive Steroids Therapy Does Not Modulate Serum Level of Neuroactive Steroids

Ambulatory Neuroproprioceptive Facilitation and Inhibition Physical Therapy Does Not Modulate Serum Level of Neuroactive Steroids

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Charles University, Czech Republic · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study describes modulation of neuroproprioceptive facilitation and inhibition physical therapy on serum level of neuroactive steroids in multiple sclerosis.

Detailed description

In the parallel group, single blind, randomized controlled trial, participant underwent two kinds of neuroproprioceptive PT (MPAT and VRL). At baseline and after the end of the two months' therapeutic program, a blinded assessor evaluated clinical outcomes and data from serum level.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNeuroproprioceptive facilitation and inhibition physical therapyAll groups underwent two months' therapy, 16 face-to-face sessions (1 hour, twice a week for two months).

Timeline

Start date
2015-05-20
Primary completion
2017-05-20
Completion
2019-09-01
First posted
2020-05-07
Last updated
2020-05-07

Source: ClinicalTrials.gov record NCT04379193. Inclusion in this directory is not an endorsement.

Physical Therapy and Neuroactive Steroids Therapy Does Not Modulate Serum Level of Neuroactive Steroids (NCT04379193) · Clinical Trials Directory